These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30889905)

  • 21. Comparative effects of choline chloride and phosphatidylcholine on plasma and liver lipid levels in rats fed a choline-deficient high cholesterol diet.
    Sugiyama K; Mochizuki C; Muramatsu K
    J Nutr Sci Vitaminol (Tokyo); 1987 Oct; 33(5):369-76. PubMed ID: 3443887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function.
    Rust P; Eichler I; Renner S; Elmadfa I
    Ann Nutr Metab; 2000; 44(1):30-7. PubMed ID: 10838464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taurine supplementation does not decrease homocysteine levels and liver injury induced by a choline-deficient diet.
    Deminice R; Rosa FT; da Silva LE; Jordao AA
    Life Sci; 2014 Jun; 105(1-2):43-7. PubMed ID: 24769283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of choline deficiency and supplementation on lipid droplet accumulation in bovine primary liver cells in vitro.
    Lu W; Yang J; Hu M; Zhong K; Wang Y; Yang Y; Loor JJ; Yang G; Han L
    J Dairy Sci; 2023 Dec; 106(12):9868-9878. PubMed ID: 37678795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men.
    Olthof MR; Brink EJ; Katan MB; Verhoef P
    Am J Clin Nutr; 2005 Jul; 82(1):111-7. PubMed ID: 16002808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR.
    Rowe SM; McColley SA; Rietschel E; Li X; Bell SC; Konstan MW; Marigowda G; Waltz D; Boyle MP;
    Ann Am Thorac Soc; 2017 Feb; 14(2):213-219. PubMed ID: 27898234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection.
    Reid DW; Withers NJ; Francis L; Wilson JW; Kotsimbos TC
    Chest; 2002 Jan; 121(1):48-54. PubMed ID: 11796431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis.
    Niebergall LJ; Jacobs RL; Chaba T; Vance DE
    Biochim Biophys Acta; 2011 Dec; 1811(12):1177-85. PubMed ID: 21745592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
    Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
    J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fat-soluble vitamins supplementation in patients with cystic fibrosis: is enough Aquadek's®?].
    González Jiménez D; Bousoño García C; Díaz Martin JJ; Jiménez Treviño S
    Nutr Hosp; 2015 Apr; 31(4):1625-32. PubMed ID: 25795950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D supplementation for cystic fibrosis.
    Ferguson JH; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007298. PubMed ID: 19821402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis.
    Papas KA; Sontag MK; Pardee C; Sokol RJ; Sagel SD; Accurso FJ; Wagener JS
    J Cyst Fibros; 2008 Jan; 7(1):60-7. PubMed ID: 17569601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study.
    Nowak JK; Wojsyk-Banaszak I; Mądry E; Wykrętowicz A; Krzyżanowska P; Drzymała-Czyż S; Nowicka A; Pogorzelski A; Sapiejka E; Skorupa W; Szczepanik M; Lisowska A; Walkowiak J
    Lung; 2017 Aug; 195(4):445-453. PubMed ID: 28646244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients.
    Ollero M; Astarita G; Guerrera IC; Sermet-Gaudelus I; Trudel S; Piomelli D; Edelman A
    J Lipid Res; 2011 May; 52(5):1011-22. PubMed ID: 21335323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of a nutrition intervention.
    Bertolaso C; Groleau V; Schall JI; Maqbool A; Mascarenhas M; Latham NE; Dougherty KA; Stallings VA
    J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):443-8. PubMed ID: 24345827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High serum retinol and lung function in young patients with cystic fibrosis.
    Rivas-Crespo MF; González Jiménez D; Acuña Quirós MD; Sojo Aguirre A; Heredia González S; Díaz Martín JJ; Garagorri Otero JM; Lázaro Almarza A; Bousoño-García C
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):657-62. PubMed ID: 23403437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of choline depletion and reduced betaine and dimethylglycine with increased homocysteine in plasma of children with cystic fibrosis.
    Innis SM; Hasman D
    J Nutr; 2006 Aug; 136(8):2226-31. PubMed ID: 16857845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma lipid concentrations in children with cystic fibrosis: the value of a high-fat diet and pancreatic supplementation.
    Burdge GC; Goodale AJ; Hill CM; Halford PJ; Lambert EJ; Postle AD; Rolles CJ
    Br J Nutr; 1994 Jun; 71(6):959-64. PubMed ID: 7518243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe Genotype, Pancreatic Insufficiency and Low Dose of Pancreatic Enzymes Associate with Abnormal Serum Sterol Profile in Cystic Fibrosis.
    Drzymała-Czyż S; Krzyżanowska-Jankowska P; Dziedzic K; Lisowska A; Kurek S; Goździk-Spychalska J; Kononets V; Woźniak D; Mądry E; Walkowiak J
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.